Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Proton pump inhibitor intake negatively affects the osseointegration of dental implants: a retrospective study

  • Altay, Mehmet Ali (Department of Oral and Maxillofacial Surgery, School of Dentistry, Akdeniz University) ;
  • Sindel, Alper (Department of Oral and Maxillofacial Surgery, School of Dentistry, Akdeniz University) ;
  • Ozalp, Oznur (Department of Oral and Maxillofacial Surgery, School of Dentistry, Akdeniz University) ;
  • Yildirimyan, Nelli (Department of Oral and Maxillofacial Surgery, School of Dentistry, Akdeniz University) ;
  • Kocabalkan, Burak (Department of Oral and Maxillofacial Surgery, School of Dentistry, Akdeniz University)
  • Received : 2018.07.11
  • Accepted : 2018.08.08
  • Published : 2019.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study sought to investigate the association between the systemic intake of proton pump inhibitors (PPI) and the early failure of dental implants. Materials and Methods: A retrospective cohort study involving 1,918 dental implants in 592 patients (69 implants in 24 PPI users and 1,849 implants in 568 nonusers, respectively) was conducted. The effect of PPI intake on the osseointegration of dental implants was evaluated using patientand implant-level models. Results: Among 24 PPI users, two patients experienced implant failure, one of whom had three and the other of whom had one failed implant, respectively. Thus, the rate of failure for this population was 8.3%. Separately, 11 nonusers each experienced one implant failure, and the failure rate for these patients was 1.9%. Fisher's exact test revealed statistically significant differences between PPI users and nonusers at the implant level (P=0.002) but failed to show any significance at the patient level (P=0.094). The odds of implant failure were 4.60 times greater among PPI users versus nonusers. Dental implants that were placed in patients using PPIs were found to be 4.30 times more likely to fail prior to loading. Conclusion: The findings of this study suggest that PPI intake may be associated with an increased risk of early dental implant failure.

Keywords

References

  1. Mangano F, Mortellaro C, Mangano N, Mangano C. Is low serum vitamin D associated with early dental implant failure? A retrospective evaluation on 1625 implants placed in 822 patients. Mediators Inflamm 2016;2016:5319718.
  2. Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Factors influencing early dental implant failures. J Dent Res 2016;95:995-1002. https://doi.org/10.1177/0022034516646098
  3. Olmedo-Gaya MV, Manzano-Moreno FJ, Canaveral-Cavero E, de Dios Luna-del Castillo J, Vallecillo-Capilla M. Risk factors associated with early implant failure: a 5-year retrospective clinical study. J Prosthet Dent 2016;115:150-5. https://doi.org/10.1016/j.prosdent.2015.07.020
  4. Koldsland OC, Scheie AA, Aass AM. Prevalence of implant loss and the influence of associated factors. J Periodontol 2009;80:1069-75. https://doi.org/10.1902/jop.2009.080594
  5. Jemt T, Olsson M, Franke Stenport V. Incidence of first implant failure: a retroprospective study of 27 years of implant operations at one specialist clinic. Clin Implant Dent Relat Res 2015;17 Suppl 2:e501-10. https://doi.org/10.1111/cid.12277
  6. Berglundh T, Persson L, Klinge B. A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol 2002;29 Suppl 3:197-212; discussion 232-3. https://doi.org/10.1034/j.1600-051X.29.s3.12.x
  7. Charyeva O, Altynbekov K, Zhartybaev R, Sabdanaliev A. Longterm dental implant success and survival--a clinical study after an observation period up to 6 years. Swed Dent J 2012;36:1-6.
  8. Albrektsson T, Branemark PI, Hansson HA, Lindstrom J. Osseointegrated titanium implants. Requirements for ensuring a longlasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981;52:155-70. https://doi.org/10.3109/17453678108991776
  9. Trindade R, Albrektsson T, Wennerberg A. Current concepts for the biological basis of dental implants: foreign body equilibrium and osseointegration dynamics. Oral Maxillofac Surg Clin North Am 2015;27:175-83. https://doi.org/10.1016/j.coms.2015.01.004
  10. Mangano C, Mangano F, Shibli JA, Ricci M, Sammons RL, Figliuzzi M. Morse taper connection implants supporting "planned" maxillary and mandibular bar-retained overdentures: a 5-year prospective multicenter study. Clin Oral Implants Res 2011;22:1117-24. https://doi.org/10.1111/j.1600-0501.2010.02079.x
  11. Apostu D, Lucaciu O, Lucaciu GD, Crisan B, Crisan L, Baciut M, et al. Systemic drugs that influence titanium implant osseointegration. Drug Metab Rev 2017;49:92-104. https://doi.org/10.1080/03602532.2016.1277737
  12. Kellesarian SV, Abduljabbar T, Vohra F, Malignaggi VR, Malmstrom H, Romanos GE, et al. Role of local alendronate delivery on the osseointegration of implants: a systematic review and metaanalysis. Int J Oral Maxillofac Surg 2017;46:912-21. https://doi.org/10.1016/j.ijom.2017.03.009
  13. Wu X, Al-Abedalla K, Eimar H, Arekunnath Madathil S, Abi- Nader S, Daniel NG, et al. Antihypertensive medications and the survival rate of osseointegrated dental implants: a cohort study. Clin Implant Dent Relat Res 2016;18:1171-82. https://doi.org/10.1111/cid.12414
  14. Wu X, Al-Abedalla K, Rastikerdar E, Abi Nader S, Daniel NG, Nicolau B, et al. Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study. J Dent Res 2014;93:1054-61. https://doi.org/10.1177/0022034514549378
  15. Al Subaie A, Emami E, Tamimi I, Laurenti M, Eimar H, Abdallah MN, et al. Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae. J Clin Periodontol 2016;43:193-203. https://doi.org/10.1111/jcpe.12506
  16. Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Intake of proton pump inhibitors is associated with an increased risk of dental implant failure. Int J Oral Maxillofac Implants 2017;32:1097-102. https://doi.org/10.11607/jomi.5662
  17. Wu X, Al-Abedalla K, Abi-Nader S, Daniel NG, Nicolau B, Tamimi F. Proton pump inhibitors and the risk of osseointegrated dental implant failure: a cohort study. Clin Implant Dent Relat Res 2017;19:222-32. https://doi.org/10.1111/cid.12455
  18. Leontiadis GI, Moayyedi P. Proton pump inhibitors and risk of bone fractures. Curr Treat Options Gastroenterol 2014;12:414-23. https://doi.org/10.1007/s11938-014-0030-y
  19. Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000;14:963-78. https://doi.org/10.1046/j.1365-2036.2000.00788.x
  20. Freedberg DE, Kim LS, Yang YX. The risks and benefits of longterm use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology 2017;152:706-15. https://doi.org/10.1053/j.gastro.2017.01.031
  21. Abraham NS. Proton pump inhibitors: potential adverse effects. Curr Opin Gastroenterol 2012;28:615-20. https://doi.org/10.1097/MOG.0b013e328358d5b9
  22. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296:2947-53. https://doi.org/10.1001/jama.296.24.2947
  23. Costa-Rodrigues J, Reis S, Teixeira S, Lopes S, Fernandes MH. Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity. FEBS J 2013;280:5052-64. https://doi.org/10.1111/febs.12478
  24. Dobrowolski P, Tomaszewska E, Radzki RP, Bienko M, Wydrych J, Zdybel A, et al. Can 2-oxoglutarate prevent changes in bone evoked by omeprazole? Nutrition 2013;29:556-61. https://doi.org/10.1016/j.nut.2012.07.014
  25. Devlin JW, Welage LS, Olsen KM. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: clinical efficacy, safety, and economics. Ann Pharmacother 2005;39:1844-51. https://doi.org/10.1345/aph.1G176
  26. Yu LY, Sun LN, Zhang XH, Li YQ, Yu L, Yuan ZQ, et al. A review of the novel application and potential adverse effects of proton pump inhibitors. Adv Ther 2017;34:1070-86. https://doi.org/10.1007/s12325-017-0532-9
  27. Serfaty-Lacrosniere C, Wood RJ, Voytko D, Saltzman JR, Pedrosa M, Sepe TE, et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr 1995;14:364-8. https://doi.org/10.1080/07315724.1995.10718522
  28. Boyce BF. Stomaching calcium for bone health. Nat Med 2009;15:610-2. https://doi.org/10.1038/nm0609-610
  29. Lau YT, Ahmed NN. Fracture risk and bone mineral density reduction associated with proton pump inhibitors. Pharmacotherapy 2012;32:67-79. https://doi.org/10.1002/PHAR.1007
  30. Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr 1993;123:148-54. https://doi.org/10.1016/S0022-3476(05)81561-6

Cited by

  1. Annual review of selected scientific literature: A report of the Committee on Scientific Investigation of the American Academy of Restorative Dentistry vol.124, pp.3, 2020, https://doi.org/10.1016/j.prosdent.2020.06.003
  2. Alendronate and omeprazole in combination reduce angiogenic and growth signals from osteoblasts vol.14, 2021, https://doi.org/10.1016/j.bonr.2021.100750
  3. Proton pump inhibitors and mandibular bone quality: A preliminary study vol.50, pp.6, 2021, https://doi.org/10.1259/dmfr.20200505
  4. Biomechanical and biochemical evaluation of the effect of systemic application of omeprazole on the osseointegration of titanium implants vol.7, pp.1, 2019, https://doi.org/10.1186/s40729-021-00310-5
  5. Are proton pump inhibitors associated with implant failure and peri-implantitis? vol.133, pp.1, 2019, https://doi.org/10.1016/j.oooo.2021.05.002